16 Einträge gefunden

1. Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer

   1. Höflmayer, Doris
   2. Steinhoff, Amélie
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Burandt, Eike
   7. Tsourlakis, Maria Christina

   2020 - Forschungsinformationssystem des UKE
2. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

   1. Luebke, Andreas M
   2. Attarchi-Tehrani, Ali
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Lang, Dagmar S
   6. Kluth, Martina
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
3. Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers

   1. Minner, Sarah
   2. Lutz, Jannes
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Höflmayer, Doris
   7. Burandt, Eike

   2019 - Forschungsinformationssystem des UKE
4. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

   1. Heumann, Asmus
   2. Heinemann, Nina
   3. Hube-Magg, Claudia
   4. Lang, Dagmar S
   5. Grupp, Katharina
   6. Kluth, Martina
   7. Minner, Sarah

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
5. Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability, and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer

   1. Wilczak, Waldemar
   2. Rashed, Semin
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Simon, Ronald
   6. Büscheck, Franziska
   7. Clauditz, Till Sebastian

   2017 - Forschungsinformationssystem des UKE
6. Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer

   1. Melling, Nathaniel
   2. Taskin, B
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Grob, Tobias

   2016 - Forschungsinformationssystem des UKE
7. Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers

   1. Burdelski, Christoph
   2. Kleinhans, Sandra
   3. Kluth, Martina
   4. Hube-Magg, Claudia
   5. Minner, Sarah
   6. Koop, Christina
   7. Graefen, Markus

   2016 - Forschungsinformationssystem des UKE
8. Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence

   1. Pust, Alexandra
   2. Kylies, Dominik
   3. Hube-Magg, Claudia
   4. Kluth, Martina
   5. Minner, Sarah
   6. Koop, Christina
   7. Grob, Tobias

   2016 - Forschungsinformationssystem des UKE
9. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers

   1. Burdelski, Christoph
   2. Bujupi, Erzen
   3. Tsourlakis, Maria Christina
   4. Hube-Magg, Claudia
   5. Kluth, Martina
   6. Melling, Nathaniel
   7. Lebok, Patrick

   2015 - Forschungsinformationssystem des UKE - frei zugänglich
10. High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

    1. Melling, Nathaniel
    2. Harutyunyan, Levon
    3. Hube-Magg, Claudia
    4. Kluth, Martina
    5. Simon, Ronald
    6. Lebok, Patrick
    7. Minner, Sarah

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
11. Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer

    1. Burdelski, Christoph
    2. Reiswich, V.
    3. Hube-Magg, Claudia
    4. Kluth, Martina
    5. Minner, Sarah
    6. Koop, Christina
    7. Graefen, Markus

    2015 - Forschungsinformationssystem des UKE
12. Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters

    1. Melling, Nathaniel
    2. Thomsen, Erik
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Minner, Sarah
    7. Koop, Christina

    2015 - Forschungsinformationssystem des UKE
13. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion

    1. Burdelski, Christoph
    2. Menan, Devi
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Melling, Nathaniel
    7. Minner, Sarah

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
14. Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion

    1. Grupp, Katharina
    2. Roettger, Laura
    3. Kluth, Martina
    4. Hube-Magg, Claudia
    5. Simon, Ronald
    6. Lebok, Patrick
    7. Minner, Sarah

    2015 - Forschungsinformationssystem des UKE
15. VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy

    1. Tsourlakis, Maria Christina
    2. Khosrawi, Puya
    3. Weigand, Philipp
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Minner, Sarah
    7. Koop, Christina

    2015 - Forschungsinformationssystem des UKE - frei zugänglich
16. Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer

    1. Burdelski, Christoph
    2. Strauss, Christian
    3. Tsourlakis, Maria Christina
    4. Kluth, Martina
    5. Hube-Magg, Claudia
    6. Melling, Nathaniel
    7. Lebok, Patrick

    2015 - Forschungsinformationssystem des UKE